Breast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: March 29, 2024 Report Code: GDME1719EPD-ST

Select Item

Breast Implants Pipeline Market Report Overview

Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Implants

·        Shaped Gel Implants

·        Round Gel Implants

·        Breast Meshes
Key Territories ·        The US

·        Europe

·        China

·        Australia

·        South Korea
Key Regulatory Paths ·        PMA

·        CE

·        NMPA

·        510(k)

·        TGA
Leading Companies ·        3D Bio Corp

·        Allergan Aesthetics

·        Apex Medical Device Design LLC

·        Arula Technologies

·        BellaSeno GmbH
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Breast Implants Pipeline Market Segments

The Breast Implants pipeline market can be categorized into implants, shaped gel implants, round, gel implants, and breast meshes. As of March 2024, the implants segment accounted for the highest share of the Breast Implants pipeline market.

Breast Implants Pipeline Market Analysis by Segments, 2024 (%)

Breast Implants Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Insights into the Breast Implants Pipeline Market Segments

Download a Free Report Sample

Pipeline Market Segmentation by Territories

A few of the key territories for the Breast Implants pipeline market are the US, Europe, China, Australia, and South Korea among others. As of March 2024, the US accounted for the highest number of pipeline products.

Breast Implants Pipeline Market Analysis by Territories, 2024 (%)

Breast Implants Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Breast Implants Pipeline Market

Download a Free Report Sample

Breast Implants Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Breast Implants pipeline products market are PMA, CE, NMPA, 510(k), and TGA as of March 2024, PMA was the most followed pathway for pipeline products in the market.

Breast Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Breast Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Breast Implants Pipeline Market

Download a Free Report Sample

Breast Implants Pipeline Market – Competitive Landscape

A few of the key companies associated with the Breast Implants pipeline market are 3D Bio Corp, Allergan Aesthetics, Apex Medical Device Design LLC, Arula Technologies, and BellaSeno GmbH among others.

3D Bio Corp (3D Bio): 3D Bio Corp is a biologic and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company’s pipeline products include AuriNovo, AnnuNovo, DiscNovo, and NasaNovo. It offers a bioprinting platform with an emphasis on living implants made of whole tissue for immediate use. The company also has lab and factory facilities in Ithaca, New York, and an engineering workshop in Brooklyn, New York. The company received funding from Kairos Ventures. 3D Bio is headquartered in New York, the US.

Allergan Aesthetics: Allergan Aesthetics is a pharmaceutical company that develops, manufactures, and markets a portfolio of leading aesthetics brands and products. It is headquartered in Irvine, California the US.

Breast Implants Pipeline Market Analysis by Companies, 2024

Breast Implants Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Breast Implants Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Breast Implants Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • South Korea

Breast Implants Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • 510(k)
  • TGA

Scope

This report provides:

  • Extensive coverage of the Breast Implants under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of Breast Implants and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Breast Implants under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Bio Corp
Allergan Aesthetics
Apex Medical Device Design LLC
Arula Technolgies
BellaSeno GmbH
BioPlus Co Ltd
Biostruxs LLC
Collplant Biotechnologies Ltd
Establishment Labs SA
FixNip Ltd
GC Aesthetics Plc
Healshape SAS
ImpLite Ltd.
Innovia LLC
Lattice Medical
LifeCell Corp
Melodi Health Inc
Mentor Worldwide LLC
MTF Biologics
Neosthetic, LLC
Osteopore International Pte Ltd
Plcoskin Co Ltd
PolyNovo Biomaterials Pty Ltd
Prayasta 3D Inventions Pvt Ltd
Surgalign Spine Technologies Inc
Symatese Aesthetics
Tensive SRL
TeVido BioDevices LLC

Table of Contents

1 Table of Contents 3_x000D_

1.1 List of Tables 5_x000D_

1.2 List of Figures 8_x000D_

2 Introduction 9_x000D_

2.1 Breast Implants Overview 9_x000D_

3 Products under Development 10_x000D_

3.1 Breast Implants – Pipeline Products by Stage of Development 10_x000D_

3.2 Breast Implants – Pipeline Products by Segment 11_x000D_

3.3 Breast Implants – Pipeline Products by Territory 12_x000D_

3.4 Breast Implants – Pipeline Products by Regulatory Path 13_x000D_

3.5 Breast Implants – Pipeline Products by Estimated Approval Date 14_x000D_

3.6 Breast Implants – Ongoing Clinical Trials 15_x000D_

4 Breast Implants – Pipeline Products under Development by Companies 16_x000D_

4.1 Breast Implants Companies – Pipeline Products by Stage of Development 16_x000D_

4.2 Breast Implants – Pipeline Products by Stage of Development 18_x000D_

5 Breast Implants Companies and Product Overview 20_x000D_

5.1 3D Bio Corp Company Overview 20_x000D_

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 20_x000D_

5.2 Allergan Aesthetics Company Overview 21_x000D_

5.2.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

5.3 Apex Medical Device Design LLC Company Overview 23_x000D_

5.3.1 Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

5.4 Arula Technolgies Company Overview 24_x000D_

5.4.1 Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

5.5 BellaSeno GmbH Company Overview 25_x000D_

5.5.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 25_x000D_

5.6 BioPlus Co Ltd Company Overview 30_x000D_

5.6.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30_x000D_

5.7 Biostruxs LLC Company Overview 31_x000D_

5.7.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 31_x000D_

5.8 Collplant Biotechnologies Ltd Company Overview 32_x000D_

5.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 32_x000D_

5.9 Establishment Labs SA Company Overview 34_x000D_

5.9.1 Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 34_x000D_

5.10 FixNip Ltd Company Overview 46_x000D_

5.10.1 FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 46_x000D_

5.11 GC Aesthetics Plc Company Overview 47_x000D_

5.11.1 GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 47_x000D_

5.12 Healshape SAS Company Overview 50_x000D_

5.12.1 Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 50_x000D_

5.13 ImpLite Ltd. Company Overview 51_x000D_

5.13.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51_x000D_

5.14 Innovia LLC Company Overview 52_x000D_

5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52_x000D_

5.15 Lattice Medical Company Overview 53_x000D_

5.15.1 Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 53_x000D_

5.16 LifeCell Corp Company Overview 56_x000D_

5.16.1 LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 56_x000D_

5.17 Melodi Health Inc Company Overview 57_x000D_

5.17.1 Melodi Health Inc Pipeline Products & Ongoing Clinical Trials Overview 57_x000D_

5.18 Mentor Worldwide LLC Company Overview 58_x000D_

5.18.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 58_x000D_

5.19 MTF Biologics Company Overview 59_x000D_

5.19.1 MTF Biologics Pipeline Products & Ongoing Clinical Trials Overview 59_x000D_

5.20 Neosthetic, LLC Company Overview 60_x000D_

5.20.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 60_x000D_

5.21 Osteopore International Pte Ltd Company Overview 61_x000D_

5.21.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 61_x000D_

5.22 Plcoskin Co Ltd Company Overview 62_x000D_

5.22.1 Plcoskin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62_x000D_

5.23 PolyNovo Biomaterials Pty Ltd Company Overview 63_x000D_

5.23.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 63_x000D_

5.24 Prayasta 3D Inventions Pvt Ltd Company Overview 64_x000D_

5.24.1 Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 64_x000D_

5.25 Surgalign Spine Technologies Inc Company Overview 65_x000D_

5.25.1 Surgalign Spine Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65_x000D_

5.26 Symatese Aesthetics Company Overview 66_x000D_

5.26.1 Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 66_x000D_

5.27 Tensive SRL Company Overview 69_x000D_

5.27.1 Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 69_x000D_

5.28 TeVido BioDevices LLC Company Overview 72_x000D_

5.28.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 72_x000D_

6 Breast Implants- Recent Developments 73_x000D_

6.1 Mar 19, 2024: The Aesthetic Society and The Aesthetic Foundation Launch ARISE– American Registry for Breast Implant Surveillance 73_x000D_

6.2 Jan 31, 2024: New Investigator-Initiated Clinical Trials of BellaSeno´s Resorbable Tissue Regeneration scaffolds to be Conducted in Europe 74_x000D_

6.3 Jan 26, 2024: New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics’ PERLE Breast Implant 74_x000D_

6.4 Jan 08, 2024: Collplant’s CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California 75_x000D_

6.5 Jan 02, 2024: Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander 75_x000D_

6.6 Jan 02, 2024: Collplant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants 76_x000D_

6.7 Nov 10, 2023: PIP Breast Implants: Last Claim for Damages against TUV Rheinland in Germany Definitively Dismiss 76_x000D_

6.8 Nov 09, 2023: Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China 77_x000D_

6.9 Oct 30, 2023: Motiva Receives 510(K) Clearance For Motiva Flora SmoothSilk Tissue Expander 77_x000D_

6.10 Oct 26, 2023: GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally 78_x000D_

6.11 Oct 24, 2023: MTF Biologics Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction 78_x000D_

6.12 Oct 16, 2023: FDA clears Establishment Labs’ magnetic-free breast tissue expander 79_x000D_

6.13 Oct 13, 2023: Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants 79_x000D_

6.14 Sep 05, 2023: BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds 80_x000D_

6.15 Jul 11, 2023: Sientra High-Strength Cohesive Silicone Gel Breast Implants Launch in Canada 80_x000D_

6.16 Jun 20, 2023: BellaSeno Demonstrates Superior Biomechanical Properties of its 3-D Printed, Resorbable Scaffolds for Bone Reconstruction 81_x000D_

6.17 Jun 08, 2023: Sientra Announces FDA-Clearance of Next Generation ALLOX2 Pro Tissue Expander 82_x000D_

6.18 May 25, 2023: Decisions of the French Supreme Court in the PIP Breast Implant Case 83_x000D_

6.19 May 09, 2023: Positive interim data of BellaSeno’s clinical trial with resorbable breast and chest implants reported at RACS 2023 83_x000D_

6.20 Apr 20, 2023: Establishment Labs notes presentation of 3-year results from Motiva U.S. IDE study at The Aesthetic Meeting 2023 84_x000D_

6.21 Apr 10, 2023: Establishment Labs begins a new era in breast aesthetics with launch of Mia Femtech in Japan 85_x000D_

7 Appendix 87_x000D_

7.1 Methodology 87_x000D_

7.2 About GlobalData 90_x000D_

7.3 Contact Us 90_x000D_

7.4 Disclaimer 90

Table

Breast Implants – Pipeline Products by Stage of Development 10

Breast Implants – Pipeline Products by Segment 11

Breast Implants – Pipeline Products by Territory 12

Breast Implants – Pipeline Products by Regulatory Path 13

Breast Implants – Pipeline Products by Estimated Approval Date 14

Breast Implants – Ongoing Clinical Trials 15

Breast Implants Companies – Pipeline Products by Stage of Development 16

Breast Implants – Pipeline Products by Stage of Development 18

3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 20

3D Printed Breast Implant – Lupectomy Reconstruction – Product Status 20

3D Printed Breast Implant – Lupectomy Reconstruction – Product Description 20

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 21

Inspira TF2 – Breast Augmentation – Product Status 21

Inspira TF2 – Breast Augmentation – Product Description 21

Larger Inspira TE – Product Status 22

Larger Inspira TE – Product Description 22

Phoenix – Breast Augmentation – Product Status 22

Phoenix – Breast Augmentation – Product Description 22

Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 23

DefyGravity – Product Status 23

DefyGravity – Product Description 23

Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 24

Breast Prosthesis – Product Status 24

Breast Prosthesis – Product Description 24

BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 25

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Status 25

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Product Description 25

Senella Scaffold – Product Status 26

Senella Scaffold – Product Description 26

BellaSeno GmbH – Ongoing Clinical Trials Overview 27

Senella Scaffold – Clinical Trial Evaluating Feasibility and Safety of Medical-grade Polycaprolactone-PCL Breast Scaffold Implantation with Autologous Fat Grafting for Breast Implant Revision and Congenital Defect Correction Surgery 28

3D Printed Pectus Scaffold Implant – Pectus Excavatum – A Clinical Trial Evaluating Medical-Grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage 29

3D Printed Pectus Scaffold Implant – Pectus Excavatum – An Investigator-Initiated Clinical Trial to Evaluate the Effect of Novel Regenerative Scaffolds for Bone Reconstruction and Chest-Wall Defects (Pectus Excavatum) 29

3D Printed Pectus Scaffold Implant – Pectus Excavatum – Clinical Trial Evaluating Medical-grade Polycaprolactone-PCL Pectus Scaffold Implantation with Autologous Fat Grafting for Pectus Excavatum Camouflage (IT) 29

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Biological Breast – Product Status 30

Biological Breast – Product Description 30

Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 31

BioBreast Scaffold – Product Status 31

BioBreast Scaffold – Product Description 31

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

3D Bioprinted Regenerative Breast Implant – Product Status 32

3D Bioprinted Regenerative Breast Implant – Product Description 32

Injectable Breast Implant – Product Status 33

Injectable Breast Implant – Product Description 33

Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 34

Mia Femtech – Product Status 34

Mia Femtech – Product Description 35

Motiva Ergonomix – Product Status 35

Motiva Ergonomix – Product Description 35

Motiva Ergonomix2 – Product Status 36

Motiva Ergonomix2 – Product Description 36

Motiva Ergonomix2 Diamond Breast Implant – Product Status 36

Motiva Ergonomix2 Diamond Breast Implant – Product Description 37

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Status 37

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Product Description 37

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Status 38

Motiva Implant Matrix VelvetSurface PLUS With Q Inside Safety – Product Description 38

Motiva MIA – Product Status 38

Motiva MIA – Product Description 39

Motiva Round – Product Status 39

Motiva Round – Product Description 39

Establishment Labs SA – Ongoing Clinical Trials Overview 40

Motiva Round – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 41

Motiva Round – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 41

Motiva Implant Matrix SilkSurface PLUS With Q Inside Safety – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 42

Motiva Ergonomix – Study of the Long-Term Effectiveness of the Motiva Implants Round and Round Ergonomix in Primary and Revision Breast Augmentation 43

Motiva Ergonomix – Study of the Safety and Effectiveness of the Motiva Implants Silicone Gel-filled Breast Implants SmoothSilk/SilkSurface in Subjects who are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction and Revision Surgery 43

Motiva Ergonomix2 – Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study 44

Motiva MIA – A Study to Evaluate the Motiva Mia System for Minimally Invasive Augmentation in Patients Undergoing Breast Implants 45

FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

FixNip NRI – Product Status 46

FixNip NRI – Product Description 46

GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 47

PERLE – Product Status 47

PERLE – Product Description 47

GC Aesthetics Plc – Ongoing Clinical Trials Overview 48

PERLE – A Prospective, Multi-center, Observational, Non Comparative, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Nagor PERLE Range of Silicone Breast Implants When Used in Breast Implantation 49

Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 50

3D Printed Breast Implant – Product Status 50

3D Printed Breast Implant – Product Description 50

ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51

Freedom Implant – Product Status 51

Freedom Implant – Product Description 51

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52

Breast Implant Shell – Product Status 52

Breast Implant Shell – Product Description 52

Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 53

MATTISSE – Product Status 53

MATTISSE – Product Description 53

Lattice Medical – Ongoing Clinical Trials Overview 54

MATTISSE – First-in-human Study of MATTISSE® Tissue Engineering Chamber in Adult Female After Total Mastectomy for Breast Cancer in Immediate or Delayed 2-stage Tissue Expander Reconstruction or Conversion From Implant-based to Autologous Reconstruction 55

LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 56

Artia – Breast Reconstruction – Product Status 56

Artia – Breast Reconstruction – Product Description 56

Melodi Health Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Melodi Matrix – Product Status 57

Melodi Matrix – Product Description 57

Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 58

Mentor – Becker Round Adjustable Gel Implant – Product Status 58

Mentor – Becker Round Adjustable Gel Implant – Product Description 58

MTF Biologics Pipeline Products & Ongoing Clinical Trials Overview 59

FlexHD Pliable – Implant-Based Breast Reconstruction – Product Status 59

FlexHD Pliable – Implant-Based Breast Reconstruction – Product Description 59

Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 60

Neosthetic Breast Implant – Product Status 60

Neosthetic Breast Implant – Product Description 60

Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Breast Reconstruction Device – Product Status 61

Breast Reconstruction Device – Product Description 61

Plcoskin Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

3D Printed Breast Implant – Product Status 62

3D Printed Breast Implant – Product Description 62

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

NovoSorb – Breast Reconstruction – Product Status 63

NovoSorb – Breast Reconstruction – Product Description 63

Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

Silicone-Based Breast Prosthesis – Product Status 64

Silicone-Based Breast Prosthesis – Product Description 64

Surgalign Spine Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Cortiva Allograft Dermis Implant – Breast Reconstruction – Product Status 65

Cortiva Allograft Dermis Implant – Breast Reconstruction – Product Description 65

Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 66

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Status 66

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Product Description 66

Symatese Aesthetics – Ongoing Clinical Trials Overview 67

ESTYME MATRIX Silicone Gel-Filled Breast Implant – Evaluation of the Safety and Performance of Symatese Aesthetics Estyme Matrix Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation, Primary Intention (EMMA Study) 68

Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 69

REGENERA Breast Implant – Product Status 69

REGENERA Breast Implant – Product Description 69

Tensive SRL – Ongoing Clinical Trials Overview 70

REGENERA Breast Implant – A Pilot Study of REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy – Long-term Follow-up 71

TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 72

3D Printed Breast Implant – Product Status 72

3D Printed Breast Implant – Product Description 72

Glossary 89

Figures

Breast Implants – Pipeline Products by Stage of Development 10

Breast Implants – Pipeline Products by Segment 11

Breast Implants – Pipeline Products by Territory 12

Breast Implants – Pipeline Products by Regulatory Path 13

Breast Implants – Pipeline Products by Estimated Approval Date 14

Breast Implants – Ongoing Clinical Trials 15

Frequently asked questions

Breast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Breast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Breast Implants reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Breast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Breast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more